Osimertinib AZD9291 is a significant chemical entity within the pharmaceutical landscape, primarily recognized for its role as a crucial intermediate in the synthesis of the anticancer drug Osimertinib. This article provides a comprehensive overview, detailing its properties, manufacturing, and ultimate application in therapeutic contexts.

The compound is typically supplied as a white crystalline powder, meeting high purity standards (>99%) verified through analytical techniques such as HPLC. Its molecular formula (C28H33N7O2) and weight (499.61) are critical for chemical reactions, while its CAS number, 1369773-39-6, serves as a unique identifier. The packaging, often in vacuum-sealed foil bags, is designed to preserve its stability and purity during transport and storage, ensuring its suitability for pharmaceutical use.

The primary function of Osimertinib AZD9291 is as a pharmaceutical intermediate for producing APIs used in targeted cancer treatments. Its application is particularly relevant in the development of drugs that inhibit specific molecular pathways implicated in cancer growth, such as those related to EGFR mutations in lung cancer. The consistent availability and quality of this intermediate are essential for pharmaceutical companies engaged in the research, development, and manufacturing of these advanced therapies.

The market for such intermediates is driven by innovation and the need for reliable supply chains. Manufacturers like those adhering to GMP and other international quality standards are vital partners for pharmaceutical firms. By understanding the detailed specifications and reliable sourcing of compounds like Osimertinib AZD9291, the industry can continue to push the boundaries of medical science, bringing effective treatments to patients who need them most.